Lindbrook Capital, LLC - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 24 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 9.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2021$21,00011,5000.00%
Other shareholders

There were no reported owners of GALMED PHARMACEUTICALS LTD in Q4 2021.

NameSharesValueWeighting ↓
View complete list of GALMED PHARMACEUTICALS LTD shareholders